FDA Approves Darolutamide for Metastatic Castration-Sensitive Prostate Cancer By Ogkologos - June 27, 2025 349 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the ARANOTE study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Granting a Marketing Authorisation for Poherdy Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with Solid Cancers FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer MOST POPULAR How to Maintain Your Sexual Health During and After Lung Cancer November 10, 2020 Feeding the Gut July 14, 2023 4 Steps We Can All Take on World Cancer Day to... February 3, 2023 FDA Approves Obecabtagene Autoleucel for Adults with Relapsed or Refractory B-Cell... December 3, 2024 Load more HOT NEWS Moving target – retrotransposable elements and cancer Sustainability a major focus of our 17th year partnering with TK... Palbociclib Plus Endocrine Therapy Does Not Improve PFS over Capecitabine in... Celebrate with Us! Vaccine Rollouts Mark the Light at the End...
